Roberto Wandenkolk Vieira

CIK: 0002150104

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)11 (68.8%)

Position reduction

Option Exercises (M)2 (12.5%)

Derivative conversions

Awards (A)2 (12.5%)

Compensation grants

Other (G, F, J, C, D, …)1 (6.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

CORT

CORCEPT THERAPEUTICS INC

Officer

Discretionary Trading P&L

Holdings

Transaction History (16 total)

CORT
CORCEPT THERAPEUTICS INC
Oct 2, 2026
Exercise(M)
Direct
8.3K shares at avg. $21.63$180K
CORT
CORCEPT THERAPEUTICS INC
Oct 2, 2026
Sale(S)
Direct
1.1K shares at avg. $114.52$126K
CORT
CORCEPT THERAPEUTICS INC
Oct 2, 2026
Sale(S)
Direct
2.1K shares at avg. $115.73$241K
CORT
CORCEPT THERAPEUTICS INC
Oct 2, 2026
Sale(S)
Direct
5.1K shares at avg. $116.58$600K
CORT
CORCEPT THERAPEUTICS INC
Sep 16, 2026
Sale(S)
Direct
296 shares at avg. $100.82$30K
CORT
CORCEPT THERAPEUTICS INC
Sep 2, 2026
Sale(S)
Direct
1.2K shares at avg. $115.44$141K
CORT
CORCEPT THERAPEUTICS INC
Sep 2, 2026
Tax Payment(F)
Direct
102 shares at avg. $113.38$12K
CORT
CORCEPT THERAPEUTICS INC
Sep 2, 2026
Exercise(M)
Direct
58.3K shares at avg. $21.63$1.3M
CORT
CORCEPT THERAPEUTICS INC
Sep 2, 2026
Sale(S)
Direct
23.6K shares at avg. $109.35$2.6M
CORT
CORCEPT THERAPEUTICS INC
Sep 2, 2026
Sale(S)
Direct
23.8K shares at avg. $110.70$2.6M
CORT
CORCEPT THERAPEUTICS INC
Sep 2, 2026
Sale(S)
Direct
1.5K shares at avg. $111.37$171K
CORT
CORCEPT THERAPEUTICS INC
Sep 2, 2026
Sale(S)
Direct
974 shares at avg. $112.40$109K
CORT
CORCEPT THERAPEUTICS INC
Sep 2, 2026
Sale(S)
Direct
1.6K shares at avg. $113.72$183K
CORT
CORCEPT THERAPEUTICS INC
Sep 2, 2026
Sale(S)
Direct
5.6K shares at avg. $114.58$644K
CORT
CORCEPT THERAPEUTICS INC
Sep 1, 2026
Award(A)
Direct
138 shares at avg. $113.38$16K
CORT
CORCEPT THERAPEUTICS INC
Sep 1, 2026
Award(A)
Direct
138 shares-

		Type	Shares	Price		Ownership
Oct 2, 2026	CORT CORCEPT THERAPEUTICS INC	Exercise(M)	8,333	$21.63	$180,243	Direct
Oct 2, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	1,100	$114.52	$125,973	Direct
Oct 2, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	2,086	$115.73	$241,412	Direct
Oct 2, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	5,147	$116.58	$600,063	Direct
Sep 16, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	296	$100.82	$29,843	Direct
Sep 2, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	1,225	$115.44	$141,413	Direct
Sep 2, 2026	CORT CORCEPT THERAPEUTICS INC	Tax Payment(F)	102	$113.38	$11,565	Direct
Sep 2, 2026	CORT CORCEPT THERAPEUTICS INC	Exercise(M)	58,333	$21.63	$1,261,743	Direct
Sep 2, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	23,600	$109.35	$2,580,674	Direct
Sep 2, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	23,770	$110.70	$2,631,349	Direct
Sep 2, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	1,537	$111.37	$171,181	Direct
Sep 2, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	974	$112.40	$109,474	Direct
Sep 2, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	1,606	$113.72	$182,632	Direct
Sep 2, 2026	CORT CORCEPT THERAPEUTICS INC	Sale(S)	5,621	$114.58	$644,042	Direct
Sep 1, 2026	CORT CORCEPT THERAPEUTICS INC	Award(A)	138	$113.38	$15,646	Direct
Sep 1, 2026	CORT CORCEPT THERAPEUTICS INC	Award(A)	138	-	$0	Direct

1-16 of 16 transactions

About Vieira Roberto Wandenkolk

Vieira Roberto Wandenkolk (SEC CIK 0002150104) files insider reports with the SEC as President, Oncology of CORCEPT THERAPEUTICS INC (CORT).

Signal8 holds 4 ownership filings by Vieira Roberto Wandenkolk (1 Form 3, 3 Form 4), filed between Sep 3, 2026 and Oct 5, 2026. Those filings report 16 transactions, from Sep 1, 2026 to Oct 2, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Vieira Roberto Wandenkolk's filings is in REDWOOD CITY, CA.

Recent filings by Vieira Roberto Wandenkolk

Oct 2, 2026: Option exercise of CORT shares (Form 4, code M).
Oct 2, 2026: Open-market sales of CORT shares (3 lines, Form 4, code S).
Sep 16, 2026: Open-market sale of CORT shares (Form 4, code S).
Sep 2, 2026: Open-market sale of CORT shares (Form 4, code S).
Sep 2, 2026: Tax withholding of CORT shares (Form 4, code F).

Other insiders filing for CORCEPT THERAPEUTICS INC (CORT)

WILSON JAMES N, Director
Lyon Joseph Douglas
Maduck Sean
Gunn Justin Frederick
Robb Gary Charles, Chief Business Officer
Guyer William, Chief Development Officer

How to read Form 4 transaction codes